Back to search

Article

How Does Arbidol Inhibit the Novel Coronavirus SARS-CoV-2? Atomistic Insights from Molecular Dynamics Simulations

2020-06-14

Abstract excerpt

The COVID-19 pandemic is spreading at an alarming rate, posing an unprecedented threat to the global economy and human health. Broad-spectrum antivirals are currently being administered for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) treatment. China's prevention and treatment guidelines suggest the use of an anti-influenza drug, Arbidol, for the clinical treatment of COVID-19. Reports indicate th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f85e4897-6386-5597-9888-3b4485a6bda5
DOI
10.26434/chemrxiv.12464576.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 9 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
How Does Arbidol Inhibit the Novel Coronavirus SARS-CoV-2? Atomistic Insights from Molecular Dynamics SimulationsDOI 10.26434/chemrxiv.12464576.v1
Clinical Antiviral Drug Arbidol Inhibits Infection by SARS-CoV-2 and Variants through Direct Binding to the Spike Protein.Semantic proximity
Efficacy and Safety Evaluation of Arbidol in Patients with COVID-19Semantic proximity
Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy.Semantic proximity
The Disruption of SARS-CoV-2 RBD/ACE-2 Complex by Ubrogepant Is Mediated by Interface HydrationSemantic proximity
In Vitro Inhibition of SARS-CoV-2 Infection by Bromhexine hydrochlorideSemantic proximity
Allosteric communication between ACE2 active site and binding interface with SARS-CoV-2.Semantic proximity
Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2Semantic proximity
Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV‑2Semantic proximity
Molecular Docking and Dynamic Simulation-based Screening Identifies Inhibitors of targeted SARS-CoV-2 3CLpro and Human ACE2Semantic proximity
Select a neighboring publication to make it the new centre.